Showing results (301-310 of 498) with videos related to

Sort By:
Pageof 50
Blood|March 13, 2013
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosisAshutosh D Wechalekar, Stefan O Schonland, Efstathios Kastritis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ DysfunctionMorie A Gertz, Heather Landau, Raymond L Comenzo, et al.
Research in Microbiology|June 28, 2011
Production and consumption of methane in freshwater lake ecosystemsGuillaume Borrel, Didier Jézéquel, Corinne Biderre-Petit, et al.
Expert Opinion on Pharmacotherapy|April 9, 2009
Bortezomib and Waldenstrom's macroglobulinemiaLaurent Pascal, Julie Gay, Christophe Willekens, et al.
Metallomics : Integrated Biometal Science|December 24, 2014
Copper isotope effect in serum of cancer patients. A pilot studyPhilippe Télouk, Alain Puisieux, Toshiyuki Fujii, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2017
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assaysGiovanni Palladini, Arnaud Jaccard, Paolo Milani, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2020
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosisRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.
Electrophoresis|May 16, 2007
Genetic microheterogeneity of human transthyretin detected by IEFKlaus Altland, Merrill D Benson, Catherine E Costello, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 6, 2013
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosisGiovanni Montagna, Benedetta Cazzulani, Laura Obici, et al.
Leukemia|June 25, 2021
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosisAngela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar, et al.
Pageof 50